$3.99 Billion is the total value of Bain Capital Public Equity Management, LLC's 48 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RNG | RINGCENTRAL INCcl a | $36,181,000 | +17.4% | 2,425,000 | 0.0% | 0.91% | +14.7% | |
| LOCK | LIFELOCK INC | $29,422,000 | +29.5% | 1,589,510 | 0.0% | 0.74% | +26.6% | |
| KMIWS | KINDER MORGAN INC DEL*w exp 05/25/201 | $21,300,000 | +17.0% | 5,000,000 | 0.0% | 0.53% | +14.1% | |
| ZFGN | ZAFGEN INC | $20,554,000 | +56.9% | 666,480 | 0.0% | 0.52% | +53.3% | |
| FMI | FOUNDATION MEDICINE INC | $19,905,000 | +17.2% | 895,800 | 0.0% | 0.50% | +14.2% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Brookside Capital Investors, L.P. #1
- Brookside Capital Partners Fund, L.P. #2
- Brookside Capital Investors II, L.P. #3
- Brookside Capital Trading Fund, L.P. #4
- Brookside Capital Investors III, L.P. #5
- Brookside Capital Partners Fund III, L.P. #6
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CITRIX SYS INC | 18 | Q3 2018 | 6.7% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 3.5% |
| AFFIMED N V | 16 | Q1 2019 | 1.0% |
| BALL CORP | 13 | Q1 2019 | 7.2% |
| RADIUS HEALTH INC | 13 | Q2 2017 | 8.4% |
| TRANSDIGM GROUP INC | 11 | Q2 2016 | 10.1% |
| ULTA SALON COSMETCS & FRAG I | 11 | Q4 2015 | 5.4% |
| VIASAT INC | 11 | Q2 2017 | 7.5% |
| AETNA INC NEW | 11 | Q2 2017 | 4.1% |
| GODADDY INC | 10 | Q1 2019 | 5.7% |
View Bain Capital Public Equity Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Affimed N.V. | February 14, 2019 | 2,362,813 | 3.8% |
| IMMUNE DESIGN CORP. | February 14, 2019 | 892,061 | 1.8% |
| REVA Medical, Inc. | February 14, 2019 | 296,502,220 | 7.2% |
| MULESOFT, INC | February 14, 2018 | 1,404,025 | 1.9% |
| CONCERT PHARMACEUTICALS, INC. | February 28, 2014 | 1,147,833 | 6.7% |
| IDENIX PHARMACEUTICALS INC | February 12, 2014 | 13,115,858 | 9.8% |
| NORTHSTAR REALTY FINANCE CORP. | February 12, 2014 | 7,657,781 | 2.6% |
| PORTOLA PHARMACEUTICALS INC | February 12, 2014 | 400,000 | 1.0% |
| Dicerna Pharmaceuticals Inc | February 10, 2014 | 1,337,000 | 8.0% |
| RingCentral Inc | February 07, 2014 | 471,073 | 5.5% |
View Bain Capital Public Equity Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| SC 13G/A | 2019-02-14 |
| SC 13G/A | 2019-02-14 |
View Bain Capital Public Equity Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.